<DOC>
	<DOCNO>NCT00253448</DOCNO>
	<brief_summary>RATIONALE : Stereotactic radiosurgery may able send x-ray directly tumor cause less damage normal tissue . Radiation therapy use high-energy x-ray kill tumor cell . Giving stereotactic radiosurgery together radiation therapy may kill tumor cell . PURPOSE : This phase II trial study well give stereotactic radiosurgery together radiation therapy work treat patient glioblastoma multiforme .</brief_summary>
	<brief_title>Stereotactic Radiosurgery Radiation Therapy Treating Patients With Glioblastoma Multiforme</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine feasibility efficacy stereotactic radiosurgery high-risk tumor region conventional radiotherapy patient glioblastoma multiforme . - Determine overall survival patient treat regimen . Secondary - Determine 6-month progression-free survival patient treat regimen . - Determine absence tumor growth and/or activity conventional MR/MR spectroscopy image patient treated regimen . - Determine frequency severity RTOG ( Radiation Therapy Oncology Group ) CNS toxic effect patient treat regimen . - Determine neurologic function quality life patient treat regimen . OUTLINE : This pilot study . Patients undergo stereotactic radiosurgery high-risk area active tumor determine MR-spectroscopy . No 2 week later , patient undergo conventional radiotherapy daily , 5 day week , 6 week . Quality life assess baseline , weekly radiotherapy , 1 3 month completion radiotherapy , every 3 month 2 year , every 6 month 3 year , annually thereafter . After completion study treatment , patient follow periodically least 5 year . PROJECTED ACCRUAL : A total 35 patient accrue study .</detailed_description>
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm grade IV malignant glioblastoma multiforme Diagnosis surgical biopsy resection within past 5 week Postoperative diagnostic contrastenhanced MRI scan MR spectroscopy must perform prior initiate study treatment Highrisk area active tumor without margin MR spectroscopy Meets follow criterion radiosurgery : Maximum diameter â‰¤ 40 mm Located &gt; 5 mm optic nerve chiasm Does involve brainstem No multifocal recurrent malignant glioma PATIENT CHARACTERISTICS : Performance status Karnofsky 50100 % Life expectancy At least 3 month Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant Negative pregnancy test PRIOR CONCURRENT THERAPY : Chemotherapy At least 6 week since chemotherapy Concurrent chemotherapy allow Endocrine therapy Concurrent steroid allow , small therapeutic dose possible Radiotherapy No prior infield radiotherapy head neck Surgery See Disease Characteristics Recovered prior surgery postoperative complication Other Concurrent antiseizure medication allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
</DOC>